| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
85 |
| issn |
0920-1211 |
| issueIdentifier |
1 |
| pageRange |
82-85 |
| publicationName |
Epilepsy Research |
| startingPage |
82 |
| bibliographicCitation |
Sommerville KW. Bioequivalence in development of antiepileptic drugs. Epilepsy Res. 2006 Jan;68(1):82–5. doi: 10.1016/j.eplepsyres.2005.09.033. PMID: 16377144. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98da59c00bfd8e0619000c7201ca6d9d |
| date |
200601 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/16377144
https://doi.org/10.1016/j.eplepsyres.2005.09.033 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
https://portal.issn.org/resource/ISSN/0920-1211 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Bioequivalence in development of antiepileptic drugs |
| discusses |
http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0005772
http://id.nlm.nih.gov/mesh/M0022501 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D000927Q000493 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D013810
http://id.nlm.nih.gov/mesh/D003692
http://id.nlm.nih.gov/mesh/D014635Q000493
http://id.nlm.nih.gov/mesh/D000927Q000008 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22227467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663956
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3121
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617 |